We explored the characterization of the GATA family member gene status of breast cancer patients from expression patterns to prognostic values and potential clinical pathology application to provide a comprehensive understanding of GATA family utilities in breast cancer. This evidence concerns the gene QRSL1 and breast carcinoma.